Page 1 of Clinical Trials for Halozyme Therapeutics [SPONSOR-COLLABORATORS], 31 Total Matches

Show/Hide Clinical Trials Which are Not Seeking New Volunteers

1
Completed
Phase II PK Study With Humalog and Humulin R With and Without rHuPH20 in T1DM
Last Updated: May 7, 2009
Condition(s): Type 1 Diabetes Mellitus
2
Completed
A Study of the Subcutaneous Injection of a Viscous Antibody Solution With Recombinant Human Hyaluronidase
Last Updated: October 13, 2011
Condition(s): Healthy
3
Active, not recruiting
Safety Study of PEGPH20 Given to Patients With Advanced Solid Tumors
Last Updated: March 20, 2012
Condition(s): Solid Tumor
4
Recruiting
Phase 1 Safety, Tolerability and PK Study of Ondansetron and Hylenex Recombinant in Healthy Volunteers
Last Updated: April 9, 2012
Condition(s): Healthy
5
Completed
A Phase IIIB Dose Comparison Study of Subcutaneous Hydration With and Without Human Recombinant Hyaluronidase (HYLENEX) in Volunteer Subjects
Last Updated: April 5, 2006
Condition(s): Healthy
6
Active, not recruiting
Randomized, Double-blind, Crossover, PK and GD Study of CSII in Subjects With Type 1 Diabetes
Last Updated: March 6, 2012
Condition(s): Type 1 Diabetes Mellitus
7
Recruiting
Randomized, Double Blind, 2 Way Crossover Study of CSII With, Versus Without, Pretreatment With Human Hyaluronidase
Last Updated: February 29, 2012
Condition(s): Type 1 Diabetes Mellitus
8
Completed
Pharmacokinetic (PK),, Pharmacodynamic (PD) of Subcutaneously Administered Humalog® With and Without Recombinant Human Hyaluronidase (rHuPH20)and Humulin R® With and Without rHuPH20
Last Updated: June 25, 2008
Condition(s): Insulin; Diabetes; Volunteers
9
Active, not recruiting
A Safety Study of Recombinant Human Hyaluronidase (Chemophase) in Combination With Mitomycin in Patients With Superficial Bladder Cancer
Last Updated: April 3, 2008
Condition(s): Bladder Cancer
10
Active, not recruiting
Safety/Efficacy Study of Subcutaneously Injected Prandial Insulins Compared to Insulin Lispro Alone in Patients With Type 1 Diabetes Mellitus
Last Updated: February 14, 2011
Condition(s): Diabetes Mellitus, Type 1
11
Completed
Study of the Intradermal Injection of rHuPH20 or Placebo in Subjects With Nickel Allergic Contact Dermatitis
Last Updated: August 27, 2010
Condition(s): Dermatitis, Allergic Contact
12
Completed
Pharmacokinetic and Glucodynamic Crossover Study of SC Administered Insulin Lispro +rHuPH20 and Regular Human Insulin +rHuPH20 Compared to Insulin Lispro Alone
Last Updated: October 1, 2009
Condition(s): Healthy Volunteers
13
Recruiting
Study of Gemcitabine + PEGPH20 vs Gemcitabine Alone in Stage IV Previously Untreated Pancreatic Cancer
Last Updated: March 22, 2012
Condition(s): Stage IV Pancreatic Cancer
14
Completed
Liquid Meal Study With Insulin Lispro With/Without rHuPH20 and Regular Human Insulin With rHuPH20 to Compare Pharmacokinetics, Postprandial Glycemic Response, and Optimal Insulin Dose in Patients With T2DM
Last Updated: June 22, 2010
Condition(s): Diabetes Mellitus, Type 2
15
Active, not recruiting
Safety Study of Subcutaneously Injected Prandial INSULIN-PH20 NP Compared to Insulin Analog Injection in Patients With Type 1 Diabetes Mellitus
Last Updated: June 22, 2010
Condition(s): Diabetes Mellitus, Type 1
16
Active, not recruiting
Safety/Efficacy Study of Subcutaneously Injected Prandial Insulins Compared to Insulin Lispro Alone in Patients With Type 2 Diabetes Mellitus
Last Updated: February 14, 2011
Condition(s): Diabetes Mellitus, Type II
17
Active, not recruiting
Pharmacokinetic, Safety and Tolerability Study of SC Administered Bisphosphonate With rHuPH20 vs Bisphosphonate Alone
Last Updated: June 3, 2009
Condition(s): Risk Factors for or a Diagnosis of Osteoporosis
18
Completed
Study of Subcutaneous Hydration Enabled by Human Recombinant Hyaluronidase (Hylenex)
Last Updated: April 27, 2010
Condition(s): Healthy
19
Active, not recruiting
Dose-Ranging, Pharmacokinetic (PK), Glucodynamic (GD), Safety and Tolerability Study of Subcutaneously (SC) Administered Humulin R and Humalog With or Without rHuPH20
Last Updated: December 3, 2009
Condition(s): Healthy Volunteers
20
Completed
Subcutaneous Rehydration Compared to Intravenous Rehydration
Last Updated: December 2, 2011
Condition(s): Dehydration

Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.

The URL of this page is: http://clinicaltrialsfeeds.org/clinical-trials/results/?spons=Halozyme+Therapeutics

Page 1 of Clinical Trials for Halozyme Therapeutics [SPONSOR-COLLABORATORS], 31 Total Matches

Get the Latest Results via Email or RSS

Subscribe via Web Newsreaders

Browse

Clinical Trials Background

About